Cargando…
Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders
Autores principales: | Ready, Kaylene, Johansen Taber, Katherine A., Bonhomme, Natasha, Lichtenfeld, J. Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752303/ https://www.ncbi.nlm.nih.gov/pubmed/30686823 http://dx.doi.org/10.1038/s41436-018-0430-9 |
Ejemplares similares
-
Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes
por: Bucheit, Leslie, et al.
Publicado: (2019) -
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
por: Vysotskaia, Valentina, et al.
Publicado: (2019) -
Genetic testing for hereditary breast cancer in Poland: 1998–2022
por: Gronwald, Jacek, et al.
Publicado: (2023) -
Academic harassment: The need for interdependent actions of stakeholders
por: Täuber, Susanne, et al.
Publicado: (2022) -
Stakeholder alliances are essential to reduce the scourge of plastic pollution
por: Lampitt, Richard S., et al.
Publicado: (2023)